VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | -100.0% | 1,600 | -50.2% | 0.00% | -100.0% |
| Q2 2022 | $20,000 | -13.0% | 3,210 | -80.8% | 0.00% | +100.0% |
| Q1 2022 | $23,000 | -91.9% | 16,700 | -67.2% | 0.00% | -91.7% |
| Q4 2021 | $284,000 | -40.1% | 50,937 | +367.4% | 0.01% | -42.9% |
| Q3 2021 | $474,000 | +5166.7% | 10,898 | +354.5% | 0.02% | – |
| Q2 2021 | $9,000 | -81.6% | 2,398 | -73.1% | 0.00% | -100.0% |
| Q1 2021 | $49,000 | +113.0% | 8,900 | -5.4% | 0.00% | +100.0% |
| Q4 2020 | $23,000 | -83.5% | 9,406 | +12.2% | 0.00% | -87.5% |
| Q3 2020 | $139,000 | +239.0% | 8,386 | +59.1% | 0.01% | +300.0% |
| Q2 2020 | $41,000 | +272.7% | 5,270 | +229.4% | 0.00% | +100.0% |
| Q1 2020 | $11,000 | – | 1,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
| INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
| Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
| Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
| Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
| Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
| Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
| Capital International Investors | 983,300 | $12,365,000 | 0.00% |
| Blackstone Inc. | 35,000 | $440,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |